I 

117TH CONGRESS 

1ST SESSION H. R. 1185 

To amend the Public Health Service Act to authorize grants to certain 

States to inform patients about the risks of opioids and their analogues, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 18, 2021 

Mr. TRONE (for himself, Mr. RESCHENTHALER, Ms. LEGER FERNANDEZ, and 

Mr. MCKINLEY) introduced the following bill; which was referred to the 

Committee on Energy and Commerce 

A BILL 

To amend the Public Health Service Act to authorize grants 

to certain States to inform patients about the risks of 

opioids and their analogues, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Opioid Patients’ Right 

5 to Know Act of 2021’’. 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 1185 IH

1 SEC. 2. GRANT PROGRAM TO INFORM PATIENTS ABOUT 

2 THE RISKS OF OPIOIDS AND THEIR ANA3 LOGUES. 

4 Part J of title III of the Public Health Service Act 

5 (42 U.S.C. 280b et seq.) is amended by inserting after 

6 section 392A (42 U.S.C. 280b–1) the following: 

7 ‘‘SEC. 392B. GRANT PROGRAM TO INFORM PATIENTS ABOUT 

8 THE RISKS OF OPIOIDS AND THEIR ANA9 LOGUES. 

10 ‘‘(a) IN GENERAL.—The Secretary, acting through 

11 the Director of the Centers for Disease Control and Pre12 vention, shall award one grant (over the life of the pro13 gram under this section) to each eligible State to inform 

14 covered health care providers about— 

15 ‘‘(1) the requirement of the State described in 

16 subsection (b); and 

17 ‘‘(2) recommendations for safe opioid pre18 scribing. 

19 ‘‘(b) ELIGIBILITY.—To be eligible to receive a grant 

20 under subsection (a), a State must have in effect a law 

21 or regulation requiring covered health care providers, be22 fore issuing a new prescription for a covered drug or ana23 logue, to inform the patient involved, and the patient’s 

24 guardian if the patient has a guardian, about— 

25 ‘‘(1) the risks of such covered drug or analogue; 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HR 1185 IH

1 ‘‘(2) the addictive qualities of such covered drug 

2 or analogue; and 

3 ‘‘(3) non-opioid treatments to such covered 

4 drug or analogue, as appropriate. 

5 ‘‘(c) GRANT AMOUNT.—The amount of a grant to a 

6 State under this section— 

7 ‘‘(1) shall be greater than the amount of each 

8 grant to a State with a smaller number of covered 

9 health providers, as estimated by the Secretary; 

10 ‘‘(2) shall not exceed $1,000,000; and 

11 ‘‘(3) subject to the availability of funds, shall 

12 not be less than $750,000. 

13 ‘‘(d) DEFINITIONS.—For purposes of this section: 

14 ‘‘(1) COVERED DRUG OR ANALOGUE.—The 

15 term ‘covered drug or analogue’ means a drug that 

16 is or contains an opioid (as defined in section 102 

17 of the Controlled Substances Act) or an analogue of 

18 an opioid. 

19 ‘‘(2) COVERED HEALTH CARE PROVIDER.—The 

20 term ‘covered health care provider’ means a health 

21 care provider who issues prescriptions for a covered 

22 drug or analogue for the relief of acute pain. 


pamtmann on DSKBC07HB2PROD with BILLS
4 

•HR 1185 IH

1 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 

2 is authorized to be appropriated to carry out this section 

3 $10,000,000 for each of fiscal years 2022 through 2031.’’. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS